Advanced search

Improvement in quality of life and well-being in older patients with treatment-naive (TN) CLL : results from the randomized phase 3 study of ibrutinib (IBR) versus chlorambucil (CLB) (resonate-2™)

(2016) HAEMATOLOGICA. 101(suppl. 1). p.55-56
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Ghia, P, A Tedeschi, PM Barr, T Robak, C Owen, O Bairey, P Hillmen, et al. 2016. “Improvement in Quality of Life and Well-being in Older Patients with Treatment-naive (TN) CLL : Results from the Randomized Phase 3 Study of Ibrutinib (IBR) Versus Chlorambucil (CLB) (resonate-2TM).” In Haematologica, 101:55–56.
APA
Ghia, P., Tedeschi, A., Barr, P., Robak, T., Owen, C., Bairey, O., Hillmen, P., et al. (2016). Improvement in quality of life and well-being in older patients with treatment-naive (TN) CLL : results from the randomized phase 3 study of ibrutinib (IBR) versus chlorambucil (CLB) (resonate-2TM). HAEMATOLOGICA (Vol. 101, pp. 55–56). Presented at the 21st Congress of the European Hematology Association.
Vancouver
1.
Ghia P, Tedeschi A, Barr P, Robak T, Owen C, Bairey O, et al. Improvement in quality of life and well-being in older patients with treatment-naive (TN) CLL : results from the randomized phase 3 study of ibrutinib (IBR) versus chlorambucil (CLB) (resonate-2TM). HAEMATOLOGICA. 2016. p. 55–6.
MLA
Ghia, P, A Tedeschi, PM Barr, et al. “Improvement in Quality of Life and Well-being in Older Patients with Treatment-naive (TN) CLL : Results from the Randomized Phase 3 Study of Ibrutinib (IBR) Versus Chlorambucil (CLB) (resonate-2TM).” Haematologica. Vol. 101. 2016. 55–56. Print.
@inproceedings{8118376,
  articleno    = {abstract P217},
  author       = {Ghia, P and Tedeschi, A and Barr, PM and Robak, T and Owen, C and Bairey, O and Hillmen, P and Bartlett, NL and Li, J and Simpson, D and Grosicki, S and Devereux, S and McCarthy, H and Coutre, S and Offner, Fritz and Moreno, C and Zhou, C and Styles, L and James, DF and Kipps, TJ and Burger, JA},
  booktitle    = {HAEMATOLOGICA},
  issn         = {0390-6078},
  language     = {eng},
  location     = {Copenhagen, Denmark},
  number       = {suppl. 1},
  pages        = {abstract P217:55--abstract P217:56},
  title        = {Improvement in quality of life and well-being in older patients with treatment-naive (TN) CLL : results from the randomized phase 3 study of ibrutinib (IBR) versus chlorambucil (CLB) (resonate-2{\texttrademark})},
  volume       = {101},
  year         = {2016},
}

Web of Science
Times cited: